121 related articles for article (PubMed ID: 1781751)
1. Serum interleukin-2 receptor levels and cutaneous T-cell lymphoma.
Gilmore SJ; Benson EM; Kelly JW
Australas J Dermatol; 1991; 32(2):101-5. PubMed ID: 1781751
[TBL] [Abstract][Full Text] [Related]
2. Soluble IL2 receptor serum levels and epidermal cytokines in mycosis fungoides and related disorders.
Zachariae C; Larsen CS; Kaltoft K; Deleuran B; Larsen CG; Thestrup-Pedersen K
Acta Derm Venereol; 1991; 71(6):465-70. PubMed ID: 1685826
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin-2 receptor in Sézary syndrome: its origin and clinical application.
Bernengo MG; Fierro MT; Novelli M; Lisa F; Appino A
Br J Dermatol; 1993 Feb; 128(2):124-9. PubMed ID: 8457444
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
Nguyen GH; Olson LC; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
[TBL] [Abstract][Full Text] [Related]
5. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.
Wasik MA; Vonderheid EC; Bigler RD; Marti R; Lessin SR; Polansky M; Kadin ME
Arch Dermatol; 1996 Jan; 132(1):42-7. PubMed ID: 8546482
[TBL] [Abstract][Full Text] [Related]
6. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
[TBL] [Abstract][Full Text] [Related]
7. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders.
Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR
J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392
[TBL] [Abstract][Full Text] [Related]
8. Association of nerve growth factor, chemokine (C-C motif) ligands and immunoglobulin E with pruritus in cutaneous T-cell lymphoma.
Suga H; Sugaya M; Miyagaki T; Ohmatsu H; Fujita H; Kagami S; Asano Y; Tada Y; Kadono T; Sato S
Acta Derm Venereol; 2013 Mar; 93(2):144-9. PubMed ID: 22948508
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A
Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural morphometry in the diagnosis of mycosis fungoides and Sézary's syndrome.
Payne CM
Clin Dermatol; 1991; 9(2):187-203. PubMed ID: 1747854
[No Abstract] [Full Text] [Related]
11. A case of Sézary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma.
Carrozza PM; Kempf W; Kazakov DV; Dummer R; Burg G
Br J Dermatol; 2002 Sep; 147(3):582-6. PubMed ID: 12207606
[TBL] [Abstract][Full Text] [Related]
12. [Morphological changes in the skin and blood in Sézary's syndrome].
Tsvetkova GM; Persina IS; Padarian GN
Arkh Patol; 1982; 44(1):66-9. PubMed ID: 7065927
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble interleukin 2 receptor levels in erythrodermic cutaneous T-cell lymphoma correlate with response to photopheresis-based treatment.
Goldman BD; Oh SK; Davis BE; Kadin ME; Poiesz BJ; Koh HK
Arch Dermatol; 1993 Sep; 129(9):1166-70. PubMed ID: 8363402
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of lymphoid cells in myocosis fungoides, Sézary's syndrome and parapsoriasis en plaques.
Schmoeckel C; Burg G; Braun-Falco O
Arch Dermatol Res; 1979 Feb; 264(1):17-28. PubMed ID: 443858
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-2 receptors and cutaneous T-cell lymphoma.
Dummer R; Burg G; Nestle F; Kohl O
Cancer; 1993 Jun; 71(11):3793-5. PubMed ID: 8490933
[No Abstract] [Full Text] [Related]
16. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
17. Increased serum thymic stromal lymphopoietin levels in patients with cutaneous T cell lymphoma.
Miyagaki T; Sugaya M; Fujita H; Saeki H; Tamaki K
Clin Exp Dermatol; 2009 Jun; 34(4):539-40. PubMed ID: 19236423
[No Abstract] [Full Text] [Related]
18. [Primary cutaneous malignant lymphoma -- Sézary syndrome].
Vuković I; Stojimirović E; Milutinović S
Bilt Hematol Transfuz; 1978; 6(3):57-62. PubMed ID: 757669
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction.
Gibson JF; Huang J; Liu KJ; Carlson KR; Foss F; Choi J; Edelson R; Hussong JW; Mohl R; Hill S; Girardi M
J Am Acad Dermatol; 2016 May; 74(5):870-7. PubMed ID: 26874819
[TBL] [Abstract][Full Text] [Related]
20. Analyses of T-cell receptor beta-chain genes by Southern blotting in known and suspected cutaneous T-cell lymphoma. A study of 67 samples from 32 patients.
Wolff-Sneedorff A; Ralfkiaer E; Thomsen K; Vejlsgaard GL
Clin Exp Dermatol; 1995 Mar; 20(2):115-22. PubMed ID: 8565244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]